4Filed Jul 28, 8:00 PM ET

Scribe (SCTX) 10% Owner Jennifer Doudna Converts Derivatives

$SCTX · Scribe Therapeutics, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Scribe (SCTX) 10% Owner Jennifer Doudna Converts Derivatives

What Happened

  • Jennifer A. Doudna (reported as a 10% owner) recorded conversions of derivative securities on 2026-07-27. The filing shows an acquisition of 12,511 common shares via conversion and a disposition of 74,088 common shares (both reported as conversion of a derivative security, transaction code C). No per-share prices or cash values were reported (N/A).

Key Details

  • Transaction date: 2026-07-27; Form 4 filed 2026-07-29 (timely within reporting window).
  • Conversions reported: +12,511 shares (acquired) and -74,088 shares (disposed); prices not reported.
  • Shares owned after the transactions: not provided in the excerpt of this filing.
  • Transaction code: C (conversion of derivative security).
  • Footnote (F1): Each share of Series A‑1 Preferred Stock converts into common stock on a one‑for‑0.1689 basis at the holder's option and will convert automatically upon closing of the issuer's initial public offering; the Series A‑1 has no expiration date.
  • Filing status: No late filing indicated in the provided record.

Context

  • These were conversions of preferred/derivative securities, not open‑market buys or ordinary sales. Conversions typically reflect capital-structure adjustments (preferred → common) rather than a direct insider cash purchase or routine sell signal. Because no price or cash amounts are reported here, the transaction’s dollar value and economic impact are not disclosed in this filing.